The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
Major depressive disorder (MDD) is the leading cause of disability worldwide and is associated with high rates of suicide and medical comorbidities. Current antidepressant medications are suboptimal, as most MDD patients fail to achieve complete remission from symptoms. At present, clinicians are un...
Main Authors: | Lauren M. Webb, Kathryn E. Phillips, Man Choi Ho, Marin Veldic, Caren J. Blacker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/3/826 |
Similar Items
-
DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results
by: Martinez-Pinteño A, et al.
Published: (2021-04-01) -
Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
by: Andres Cardenas, et al.
Published: (2019-03-01) -
Systematic evaluation of DNA methylation age estimation with common preprocessing methods and the Infinium MethylationEPIC BeadChip array
by: Lisa M McEwen, et al.
Published: (2018-10-01) -
Bridging Basic and Clinical Research in Early Life Adversity, DNA Methylation, and Major Depressive Disorder
by: Amanda Brown, et al.
Published: (2019-03-01) -
Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 site
by: Brice Le François, et al.
Published: (2015-10-01)